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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S472Following a 3 bi-weekly injection regimen there was a 28% and a 37%
reduction in thewidth of signiﬁcant tibial lesions, respectively, for 10 mg
and 30 mg doses. This partial loss in efﬁcacy by conducting 3 bi-weekly
treatments rather than 6 weekly treatments was partially compensated
for by increasing the 3 injection regimen rhGDF5 dose from 30 mg to 100
mg, which reduced lesion width by 41%. In Study 3, a single rhGDF5
injection on day 21 reduced the width of signiﬁcant tibial lesions
compared with vehicle controls by 13% and 19% for a 30 mg and 100 mg
dose respectively. The 2 injection regimen administered on days 21 and
35 post MMT reduced tibial lesion width by 18% and 28%, and the 3
injection regimen reduced these lesions by 27% and 43%. After
accounting for a modest vehicle effect, the level of Day 63 cartilage
degeneration observed with 3 biweekly injections of rhGDF5 (30 or 100
mg) was signiﬁcantly less than the untreated controls at day 21. This is
indicative of disease arrest and cartilage regeneration with repeated
injections of higher doses of rhGDF5.
Conclusions: Intra-articular delivery of rhGDF5 signiﬁcantly protected
the knee joint from MMT-induced OA disease in a dose and admin-
istration regimen dependent manner. Our data indicate that even a
single injection of 100 mg rhGDF5 has signiﬁcant therapeutic beneﬁt.
Additionally, rhGDF5 is able to arrest disease progression in a ther-
apeutic modality with as few as 2 bi-weekly injections. Moreover, 3 bi-
weekly injections of 100 mg rhGDF5 was able to stimulate cartilage
regeneration in the MMT model. Collectively, these results clearly
demonstrate the potential of rhGDF5 supplementation as a targeted
therapeutic approach for treating OA.
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NOT PREDICT RESPONSE TO INTRA-ARTICULAR STEROID THERAPY
IN KNEE OA
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Purpose: Intra-articular steroid therapy is widely used in the man-
agement of osteoarthritis (OA) of the knee. Meta-analyses suggest
treatment is linked with a signiﬁcant reduction in pain at least in the
short term (< 3weeks). Steroids havemarked anti-inﬂammatory effects
and it is thought that their analgesic effect may be related in part to
this.Some knees with OA have little if any synovitis whereas in others,
synovitis, assessed as synovial volume, is similar to rheumatoid
arthritis. It is not known, however, whether response to therapy is
inﬂuenced by the degree of synovitis present nor of the presence of
bonemarrow lesions (BMLs), lesions also related to pain. The aim of this
analysis was to determine the inﬂuence of synovitis, as assessed by
synovial volume using magnetic resonance imaging (MRI), and also the
summed score of BMLs, on the symptomatic response to treatment with
intra-articular steroid therapy.
Methods: Men and women aged 40 years and older with painful knee
OA who met the American College of Rheumatology (ACR) criteria for
the disease, were recruited for participation in an ongoing open label
clinical trial of intra-articular steroid therapy. Subjects who took part in
the study had signiﬁcant knee pain and knee OA (Kellgren-Lawrence
grade 2 or more). At baseline they completed questionnaires about their
symptoms including the Knee Injury and Osteoarthritis Outcome Score
(KOOS) (0-100) with the lower scores indicating greater pain and also a
VAS (0-10) for pain during a nominated activity (VASnA) with higher
scores indicating greater pain. They subsequently had a gadoli-
nium(Gd)-enhanced MRI scan immediately prior to having an intra-
articular steroid injection (depomedrone 80 mg) with repeat ques-
tionnaires and Gd-enhanced MRI scan at follow-up visit usually within
a 2 week period. To assess synovial tissue volume, sagittal (T1W Fat
Suppressed images: TR 500ms, TE 17ms; FoV 15.9 x 15.9cm; slice
thickness 3mm) scans were obtained. Manual segmentation of the
synovial tissue layer was performed on the post-contrast knee image by
a single observer. Using computer image analysis we excluded cartilage
within the segmented space, by thresholding in the associated sagittal
(3D WATSc: TR 20ms, TE 7.7ms, FoV 15cm, 288x288) scan. The rest of
the segmented space is assumed to be a mixture of ﬂuid and synovial
tissue. We calculated the proportion of synovial tissue in every voxel
and summarized these across voxels to compute a volume of synovium.
BMLs were assessed semi-quantitatively by an experienced MSK radi-
ologist using the WORMS method (range of possible scores 0-45) andthis represented the BML score. In the analysis we looked whether the
baseline structural parameters were associated with a change in both
KOOS-pain and also VASnA.
Results: We studied 100 participants of mean age 62.0 years (SD 10.4
years) and of whom 48were female. Themedian time between baseline
and follow-up scan was 8 days (IQR 7 to 14 days). The mean synovial
tissue volume at baseline was 10,033mm3 (SD 6,495mm3), and mean
total BML score 8 (SD 5.0). Overall, pain signiﬁcantly improved fol-
lowing steroid injection as indicated by an increase in KOOS (mean
change at follow-up ¼ 22.2 points; 95% CI 18.0 to 26.4; p < 0.001) and a
reduction in VASnA (mean change at follow-up ¼ -3.1cm; 95% CI -3.7
cm to -2.5 cm; p< 0.001). Neither synovial volume (r¼ 0.026; p¼ 0.80)
nor BML score at baseline (r ¼ -0.037; p ¼ 0.72) were associated with
the observed change in KOOS-pain. Similarly neither synovial volume (r
¼ 0.064; p ¼ 0.55) nor BML score at baseline (r ¼ 0.098; p ¼ 0.37) were
associated with a change in VASnA. Overall, based on the OARSI criteria
there were 67 responders and 33 non-responders. Baseline synovial
tissue volume did not differ in those who did, compared to those who
did not, subsequently respond (mean difference ¼ -76mm3; 95% CI
-2831mm3 to 2679mm3; p ¼ 0.96). Similarly, BML score did not differ
between those who subsequently did, compared to those who did not,
respond (mean difference ¼ -0.41; 95% CI -2.53 to 1.71; p ¼ 0.70).
Conclusions: Neither synovitis nor BML score predict response to intra-
articular steroid injection in patients with symptomatic knee OA.
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Purpose: Osteoarthritis affects individual joints necessitating the need
for local therapy. Intra-articular (i.a.) injection of drugs remains inad-
equate due to rapid drug clearance from joint space. Local delivery into
cartilage is further complicated by its complex architecture of dense
